Home › Non-Small Cell Lung Cancer › California › Newport Beach
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Newport Beach, CA
14 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Newport Beach (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Nagre-recruitPhase 3
- Hoag Hospital Newport Beach, Newport Beach
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Newport Beach
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Nagre-recruitPhase 3
- Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Research Site, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of KK2269 in Adult Participants With Solid Tumors
Nagre-recruitPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Hoag Memorial Hospital, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Hoag Family Cancer Institute, Newport Beach
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Nagre-recruitPhase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Nagre-recruitPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Nagre-recruitPhase 3
- Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Nagre-recruitPhase 2
- City of Hope at Newport Beach Fashion Island, Newport Beach
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Newport Beach
- Kanser sa Suso16 pag-aaral
- Metastatic Cancer10 pag-aaral
- COPD9 pag-aaral
- Kanser sa Ovary9 pag-aaral
- Kanser ng Endometrium7 pag-aaral
- Kanser sa Baga7 pag-aaral
- Colorectal Cancer6 pag-aaral
- Kanser sa Prostate6 pag-aaral
- Triple-Negative Breast Cancer6 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg5 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.